Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00280-016-3060-4
Published Online: 2016-05-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamashita, Takaya
Fujishima, Naohito
Miura, Masatomo
Niioka, Takenori
Abumiya, Maiko
Shinohara, Yoshinori
Ubukawa, Kumi
Nara, Miho
Fujishima, Masumi
Kameoka, Yoshihiro
Tagawa, Hiroyuki
Hirokawa, Makoto
Takahashi, Naoto
License valid from 2016-05-23